Is ServiceNow's (NOW) AI 'Control Tower' Strategy Deepening Its Cross‑Industry Moat?

• In recent days, ServiceNow has expanded its AI footprint with new public sector offerings like EmployeeWorks and Autonomous Workforce, while partners including Cohesity, Aiva Health, Autonomize AI, NTT DOCOMO and StarHub announced integrations that embed ServiceNow’s AI platform into data security, healthcare, telecom roaming and payer operations workflows.
• Together with fresh recognition in a Forrester public sector cloud report and new ESOP-related shelf registrations, these moves reinforce ServiceNow’s push to act as an “AI control tower” that orchestrates mission‑critical, cross‑industry processes under tight governance and compliance requirements.
• Next, we’ll examine how ServiceNow’s Autonomous Workforce launch for government agencies shapes the existing investment narrative around AI‑driven growth.

The future of work is here. Discover the 30 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

ServiceNow Investment Narrative Recap

To own ServiceNow, you need to believe its AI platform can stay mission critical as customers rethink software around agents and automation. The key near term catalyst is whether its AI Control Tower vision converts into real, cross industry deployments faster than AI driven disruption pressures its premium valuation. The latest public sector launches and integrations appear directionally supportive of that catalyst, while the biggest risk remains intense AI competition and execution demands around new workflows and pricing models.

Among the recent announcements, the launch of Autonomous Workforce for government agencies is most relevant. It puts ServiceNow’s agentic AI story into a regulated, compliance heavy setting where reliability and governance are non negotiable. If agencies adopt Level 1 IT Service Desk AI specialists at scale, it could validate the broader “AI control tower” pitch across telecom, healthcare, and payer operations, but it also raises the bar on ServiceNow to keep investing heavily in AI quality and security.

Yet behind the AI Control Tower promise, investors should also weigh the less visible risk that rapid AI commoditization could still squeeze pricing power and...

Read the full narrative on ServiceNow (it's free!)

ServiceNow's narrative projects $20.3 billion revenue and $3.3 billion earnings by 2028. This requires 18.9% yearly revenue growth and roughly a $1.6 billion earnings increase from $1.7 billion today.

Uncover how ServiceNow's forecasts yield a $188.70 fair value, a 66% upside to its current price.

Exploring Other Perspectives

Some analysts are far more optimistic, assuming revenue could reach about US$20.3 billion and earnings US$4.2 billion by 2028, but this AI heavy, high growth story may look very different once the new government and partner AI launches are fully reflected in those forecasts, so it is worth comparing these bullish assumptions with more cautious views before you decide where you sit.

Explore 11 other fair value estimates on ServiceNow - why the stock might be worth over 2x more than the current price!

The Verdict Is Yours

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your ServiceNow research is our analysis highlighting 3 key rewards that could impact your investment decision.
• Our free ServiceNow research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate ServiceNow's overall financial health at a glance.

Interested In Other Possibilities?

These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

• This technology could replace computers: discover 23 stocks that are working to make quantum computing a reality.
• The latest GPUs need a type of rare earth metal called Neodymium and there are only 29 companies in the world exploring or producing it. Find the list for free.
• AI is about to change healthcare. These 33 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com